U.S. market Closed. Opens in 17 hours 30 minutes

FATE | Fate Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue63.53M96.30M55.85M31.43M10.68M4.74M4.11M4.40M2.43MN/A971.00K2.67M1.17M
Cost of Revenue18.28M13.76M5.85M125.62M87.77MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit45.25M82.54M50.00M-94.19M-77.09M4.74MN/AN/A2.43MN/A971.00K2.67MN/A
Operating Expenses222.86M404.69M272.84M159.52M111.41M71.83M46.23M36.37M30.21M24.90M18.65M16.23MN/A
Selling, General & Admin79.45M84.23M57.32M33.90M23.64M15.81M11.87M9.91M10.35M8.47M6.64M4.23M4.61M
Research & Development143.41M320.45M215.52M125.62M87.77M56.02M34.36M26.45M19.86M16.43M12.01M12.00M9.86M
Other Operating Expenses9.88M20.82MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-177.61M-308.39M-216.99M-128.09M-100.73M-67.09M-42.12M-31.96M-27.78M-24.90M-17.68M-13.56M-13.29M
Other Expenses / Income16.68M26.66M4.84M-45.30M2.58M494.00K-827.00K-1.50M-2.21M-979.00K-3.22M-682.00K-134.00K
Before Tax Income-160.93M-281.72M-212.15M-173.39M-98.15M-66.60M-42.95M-33.46M-29.99M-25.88M-20.89M-14.24M-13.43M
Income Tax Expenses18.11M-26.66M-5.85M-3.09M-441.00K2.19MN/AN/AN/AN/AN/AN/AN/A
Net Income-160.93M-255.06M-206.30M-170.30M-97.71M-66.60M-42.95M-33.46M-29.99M-25.88M-20.89M-14.24M-13.43M
Interest ExpensesN/A5.84MN/AN/A1.75M1.70M1.27M1.64M2.22M549.00K796.00K487.00K127.00K
Basic Shares Outstanding98.41M96.83M94.75M82.39M68.19M56.20M41.98M31.75M25.48M20.45M5.90M7.46M8.87M
Diluted Shares Outstanding98.41M96.83M94.75M82.39M68.19M56.20M41.98M31.75M25.48M20.45M5.90M7.46M8.87M
EBITDA-159.33M-308.39M-215.69M-125.69M-96.40M-64.90M-40.71M-30.94M-27.09M-24.41M-19.53M-13.16M-12.63M
EBITDA Margin-250.78%-320.23%-386.21%-399.84%-902.59%-1,369.24%-991.55%-702.95%-1,114.15%0.00%-2,011.02%-492.96%-1,079.32%
EBIT-142.81M-275.88M-212.15M-173.39M-96.40M-62.71M-41.68M-31.82M-27.77M-25.33M-20.10M-13.75M-13.30M
EBIT Margin-224.79%-286.48%-379.89%-551.59%-902.59%-1,323.04%-1,015.20%-722.97%-1,142.41%0.00%-2,069.82%-515.06%-1,136.75%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙